Table 2.
Univariate Analysis | Multivariate Analysis | |||
---|---|---|---|---|
HR (95%CI) | p Value | HR (95%CI) | p Value | |
Age | ||||
<70 | Ref. | Ref. | ||
≥70 | 1.702 (1.195, 2.424) | <0.001 | 1.798 (1.259, 2.567) | 0.001 |
Gender | ||||
female | Ref. | |||
male | 1.058 (0.703, 1.591) | 0.788 | ||
pT stage | ||||
pT1–2 | Ref. | Ref. | ||
pT3–4 | 1.938 (1.258, 2.985) | 0.003 | 1.111 (0.526, 2.345) | 0.783 |
pN stage | ||||
pN0–1 | Ref. | Ref. | ||
pN2–3 | 1.907 (1.323, 2.749) | <0.001 | 1.557 (1.014, 2.391) | 0.043 |
pM stage | ||||
pM0 | Ref. | |||
pM1 | 1.849 (0.859, 3.981) | 0.116 | ||
pTNM stage | ||||
Stage II | Ref. | Ref. | ||
Stage III–IV | 2.438 (1.591, 3.876) | <0.001 | 1.407 (0.581, 3.403) | 0.449 |
Lymphovascular invasion | ||||
No | Ref. | Ref. | ||
Yes | 1.603 (1.128, 2.277) | 0.008 | 1.360 (0.924, 2.003) | 0.119 |
eTILs | ||||
Low eTILs | Ref. | Ref. | ||
High eTILs | 0.333 (0.199, 0.558) | <0.001 | 0.345 (0.203, 0.586) | <0.001 |
95% CI, 95% Confidence Interval; HR, Hazard Ratio.